Denali develops biological medicines that can reach the brain, mainly for neurodegenerative and rare lysosomal storage diseases. It last closed at $18.45 on Nov 20, up 1.37% on the day. The next earnings report for DNLI is expected around Thu, Feb 25, 2027, after the close. For the quarter ended Sep 2026, DNLI reported EPS of $0.37 on revenue of $17.8M. Over its last 8 reports the stock moved an average of 4.1% the session after earnings. Over the last 12 months DNLI insiders bought $0 of stock on the open market and sold $1.3M, according to SEC Form 4 filings.
AI Auto Pilots
Is DNLI in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold DNLI.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on DNLIStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
DNLI · as of the Nov 20 close · updated each morning
Downtrend
The stock is 4% below its 20 day and 5% below its 50 day average. It is 15% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 44). The nearest support is the Pivot at $18.41, and the nearest resistance the Pivot R1 at $18.89.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 4.8%/day
Key levels
$27.3052 week high+48.0%
$21.76100 day average+17.9%
$21.14200 day average+14.6%
$19.4350 day average+5.3%
$19.35Swing high (Oct 20)+4.9%
$19.1620 day average+3.8%
$18.89Pivot R1+2.4%
$18.45Last close
$18.41Pivot−0.2%
$18.32Swing low (Nov 2)−0.7%
$17.96Pivot S1−2.7%
$15.3452 week low−16.9%
Indicators
RSI (14)
43.77
Middle of its range
Neutral
MACD
-0.33
Below its signal line
Bearish
Stochastic
23.5
Middle of its range
Neutral
ADX (14)
17.8
No clear trend
Williams %R
-74.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
-78.7
Oversold below −100, overbought above 100
Neutral
Rate of change
−8.1%
Change over 10 sessions
Bearish
ATR (14)
$0.88
Typical daily range, 4.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 11.8%/day
Key levels
$27.3052 week high+48.0%
$21.76100 day average+17.9%
$21.14200 day average+14.6%
$19.4350 day average+5.3%
$19.35Swing high (Oct 20)+4.9%
$19.1620 day average+3.8%
$18.89Pivot R1+2.4%
$18.45Last close
$18.41Pivot−0.2%
$18.32Swing low (Nov 2)−0.7%
$17.96Pivot S1−2.7%
$15.3452 week low−16.9%
Indicators
RSI (14)
42.21
Middle of its range
Neutral
MACD
-0.71
Below its signal line
Bearish
Stochastic
21.5
Middle of its range
Neutral
ADX (14)
21.0
Weak trend
Williams %R
-85.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-100.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−12.5%
Change over 10 sessions
Bearish
ATR (14)
$2.18
Typical daily range, 11.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Below
What happened before, for DNLI
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how DNLI did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow DNLI usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for DNLIHow many large options trades hit DNLI, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in DNLI in the last 90 days.
From SEC Form 4 filings by DNLI's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DNLI is in one of them and how their past DNLI trades turned out.
Denali is a biotechnology company based in South San Francisco, California, that develops biological medicines for serious diseases. Its TransportVehicle technology is designed to carry large molecule drugs, such as enzymes and antibodies, past the barrier that normally keeps them out of the brain. The company focuses on neurodegenerative conditions and rare lysosomal storage disorders, and its medicines are aimed at patients and the doctors who treat them.